NCT05392413
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Nanfang Hospital Guangzhou, China
Clinical trial condition
Esophageal Squamous Cell Carcinoma
Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
418 public trials
137 recruiting studies
Esophageal Squamous Cell Carcinoma trial results
Recruiting
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
NCT04973306
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
- Locations
-
- Shanghai Zhongshan Hospital Shanghai, China
NCT04807673
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
NCT04009265
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
Recruiting
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
NCT04018872
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +17 more
- Locations
-
- Dallas VA Medical Center Dallas, Texas, United States
NCT04519905
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Chemoradiotherapy, +14 more
- Locations
-
- Jiangsu Cancer Hospital Nanjing, Jiangsu, China
- Huadong Hospital Shanghai, Shanghai Municipality, China
- Fudan Universtiy Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT04522687
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +15 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not yet recruiting
PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC
NCT07836049
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
Not yet recruiting
Immunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With Residual Tumor and Positive Lymph Nodes
NCT07830355
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
Not specified
Not yet recruiting
Risk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and Surgery
NCT07822906
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +18 more
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China